December 2011

Sun Pharma make speciality pharmaceuticals and active pharmaceutical ingredients. Sun Pharma's brands are prescribed in chronic therapy areas like cardiology, psychiatry, neurology, gastroenterology, diabetology and respiratory.

ZANEKA HEALTH CARE PVT LTD. is manufacturing more than 400 formulations in the form of tablets, capsules, Dry syrup (Beta Lactum & Non Beta lactum), Ointments, Liquid Syrup & Dry Powder Injections (Beta Lactum)
They at ZANEKA believe that if their customer is happy then they are happy. They are committed to deliver high standard of product and develop products with the feedbacks from the customer and the final consumer following the proper WHO GMP guidelines.

At the Federation's 71st International Congress in Hyderabad, India, the World Health Organization (WHO) and the International Pharmaceutical Federation (FIP) signed a Joint Statement on the role of pharmacists in tuberculosis care and control

About Authors:
Nishant Gupta
Department of pharmaceutics,
B.N. College of pharmacy,
Udaipur-313002,
Rajasthan

ABSTRACT:
Paroxetine (PRX) crystals exhibit poor compressibility, poor flowability and its tablets show a tendency to cap. To improve the mechanical strength of tablets several kinds of “Paroxetine for direct compression” are present on the market. Current research demonstrated the best tablet properties with coated paroxetine (mass of tablets, diameter, height and mechanical strength, friability RSD<2%). Furthermore, coated paroxetine in combination with both investigated superdisintegrants such as Vivasol® and Polyplasdone® XL-10 shows faster disintegration time and dissolution rate in comparison to paroxetine for direct compression. Eventually, the major advantages of the formulation with coated paroxetine for industrial production are decrease of friability and superiority in terms of flowability, compressibility, quick disintegration and dissolution. Regarding the results, coating of PRX particles is beneficial for the manufacturing of tablets with immediate release.

About Authors:
Nishant Gupta
Department of pharmaceutics,
B.N. College of pharmacy,
Udaipur-313002,
Rajasthan

ABSTRACT:
Cancer is the leading cause of death in the United States among people younger than 85 years, and for the first time has surpassed heart disease as the number one killer. This worrisome statistic has resulted not from an increase in the incidence of cancer, but because deaths from heart disease have dropped nearly in half while the number of cancer-related deaths has remained about the same. This fact accentuates the need for a new generation of more effective therapies for cancer. Cancer patients are typically exposed to chemotherapy and radiation therapy in separate treatment rounds, doubling their emotional and physical stress. Biopharmaceutical researchers are now working on 887 medicines for cancer, according to a new report by the Pharmaceutical Research and Manufacturers of America (PhRMA). Many are high-tech weapons to fight the disease, while some involve innovative research into using existing medicines in new ways. Few things cause patients more fear and apprehension than a cancer diagnosis. But today—because of early detection and a steady stream of new and improved treatments—cancer increasingly can be managed and even beaten.